Patent AT-E401088-T1: [Translated] COMPOSITION OF A SURVIVIN ANTISENSE OLIGONUCLEOTIDE AND GEMCITABINE FOR THE TREATMENT OF CANCER
Description
The present invention relates to a method of treating cancer in a patient comprising administering an effective amount of a Survivin antisense oligonucleotide in combination with an effective amount of an additional anti-cancer agent.
Resources
| Name |
Format |
Description |
Link |
|
21 |
Access the complete Patent AT-E401088-T1: [Translated] COMPOSITION OF A SURVIVIN ANTISENSE OLIGONUCLEOTIDE AND GEMCITABINE FOR THE TREATMENT OF CANCER on the official website. |
https://pubchem.ncbi.nlm.nih.gov/patent/AT-E401088-T1 |
Tags
- patent
- chemistry
- research
- innovation
- pubchem